LOS ANGELES — A new study has found that the use of a urine test could significantly improve screening for prostate cancer. Prostate cancer screening is currently based on a blood test to detect PSA — ...

The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due ...

Active Surveillance Cost-Effective for Prostate Cancer But print and web-based aids do not affect screening rates. A print and web-based decision aid helps men with their decision making about ...

The use of more precise radiotherapy treatments involving MRI-planned external beam radiation therapy (EBRT) on prostate cancer patients is not only curing them, but is doing so in a way that ...

Factors influencing patients’ decision to undergo scalp cooling in breast and gynecological cancer. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include ...

RELEVANT study: Patient (Pt) and physician (PI) perspectives on meaningful outcomes in advanced pancreatic ductal adenocarcinoma (PDAC). This is an ASCO Meeting Abstract from the 2020 ASCO Quality ...

Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial ...

KINGTON, ON – Researchers at Queen's University have developed a new way of performing lab tests that could improve the way doctors manage prostate cancer treatment. It will allow them to identify ...

CINCINNATI (WKRC) - The legacy of Steve Abbott, an author who wrote about his battle with prostate cancer in the book "Survive and Advance: My Cancer Battle Fought One Laugh at a Time," helped a local ...